Brief: Femasys Inc. Receives U.S. FDA Clearance To Market Femaseed, An Innovative Infertility Treatment Solution
25/09/2023 22:27
Sept 25 (Reuters) - Femasys Inc FEMY.O :
* FEMASYS INC. RECEIVES U.S. FDA CLEARANCE TO MARKET
FEMASEED, AN
INNOVATIVE INFERTILITY TREATMENT SOLUTION
Source text for Eikon: ID:nGNX1GgQt9
Further company coverage: FEMY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Femasys
See all newsBrief: Femasys - Files For Resale Of Up To 28,124,997 Shares Of Common Stock - SEC Filing
Brief: Femasys Announces FDA Approval Of Modular Pma Submission Approach For Fembloc
Femasys Inc reports results for the quarter ended June 30 - Earnings Summary
Femasys Inc expected to post a loss of $1.30 a share - Earnings Preview
Femasys Inc expected to post a loss of $1.30 a share - Earnings Preview